{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T19:16:47Z","timestamp":1790363807814,"version":"4.1.0"},"reference-count":163,"publisher":"American Medical Association (AMA)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Pediatr"],"DOI":"10.1001\/jamapediatrics.2021.0347","type":"journal-article","created":{"date-parts":[[2021,5,10]],"date-time":"2021-05-10T12:43:02Z","timestamp":1620650582000},"page":"e210347","source":"Crossref","is-referenced-by-count":42,"title":["Association of Rotavirus Vaccines With Reduction in Rotavirus Gastroenteritis in Children Younger Than 5 Years"],"prefix":"10.1001","volume":"175","author":[{"given":"Zi-Wei","family":"Sun","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, the First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Fu","sequence":"additional","affiliation":[{"name":"Department of Pathology, the First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-Ling","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, Yancheng Traditional Chinese Medicine Hospital Affiliated to Nanjing University of Chinese Medicine, Yancheng, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui-Xia","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, the First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hemant","family":"Goyal","sequence":"additional","affiliation":[{"name":"The Wright Center of Graduate Medical Education, Scranton, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, the First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hua-Guo","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, the First Affiliated Hospital with Nanjing Medical University, Nanjing, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2021,7,6]]},"reference":[{"issue":"11","key":"poi210012r1","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1016\/S1473-3099(18)30362-1","article-title":"Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"18","author":"GBD 2016 Diarrhoeal Disease Collaborators","year":"2018","journal-title":"Lancet Infect Dis"},{"issue":"10","key":"poi210012r2","doi-asserted-by":"publisher","first-page":"958","DOI":"10.1001\/jamapediatrics.2018.1960","article-title":"Rotavirus vaccination and the global burden of rotavirus diarrhea among children younger than 5 years.","volume":"172","author":"Troeger","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"9","key":"poi210012r3","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1473-3099(17)30276-1","article-title":"Estimates of global, regional, and national morbidity, mortality, and aetiologies of diarrhoeal diseases: a systematic analysis for the Global Burden of Disease Study 2015.","volume":"17","author":"Collaborators","year":"2017","journal-title":"Lancet Infect Dis"},{"issue":"42","key":"poi210012r4","doi-asserted-by":"publisher","first-page":"937","DOI":"10.15585\/mmwr.mm6842a1","article-title":"Global routine vaccination coverage, 2018.","volume":"68","author":"Peck","year":"2019","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"5","key":"poi210012r5","first-page":"49","article-title":"Rotavirus vaccines: WHO position paper, January 2013.","volume":"88","author":"World Health Organization","year":"2013","journal-title":"Wkly Epidemiol Rec"},{"issue":"10100","key":"poi210012r7","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(17)31833-0","article-title":"Global, regional, and national under-5 mortality, adult mortality, age-specific mortality, and life expectancy, 1970-2016: a systematic analysis for the Global Burden of Disease Study 2016.","volume":"390","author":"Collaborators","year":"2017","journal-title":"Lancet"},{"issue":"9175","key":"poi210012r8","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/S0140-6736(98)12106-2","article-title":"Efficacy of live, attenuated, human rotavirus vaccine 89-12 in infants: a randomised placebo-controlled trial.","volume":"354","author":"Bernstein","year":"1999","journal-title":"Lancet"},{"issue":"6","key":"poi210012r9","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1097\/01.inf.0000164763.55558.71","article-title":"Comparative evaluation of safety and immunogenicity of two dosages of an oral live attenuated human rotavirus vaccine.","volume":"24","author":"Dennehy","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"poi210012r10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/INF.0b013e3182435afe","article-title":"Efficacy of a pentavalent human-bovine reassortant rotavirus vaccine against rotavirus gastroenteritis among American Indian children.","volume":"31","author":"Grant","year":"2012","journal-title":"Pediatr Infect Dis J"},{"issue":"9601","key":"poi210012r11","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.1016\/S0140-6736(07)61744-9","article-title":"Efficacy of human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in European infants: randomised, double-blind controlled study.","volume":"370","author":"Vesikari","year":"2007","journal-title":"Lancet"},{"issue":"32","key":"poi210012r12","doi-asserted-by":"publisher","first-page":"5272","DOI":"10.1016\/j.vaccine.2010.05.057","article-title":"Immunogenicity and safety of the human rotavirus vaccine Rotarix co-administered with routine infant vaccines following the vaccination schedules in Europe.","volume":"28","author":"Vesikari","year":"2010","journal-title":"Vaccine"},{"issue":"2","key":"poi210012r13","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.vaccine.2009.10.041","article-title":"RotaTeq, a pentavalent rotavirus vaccine: efficacy and safety among infants in Europe.","volume":"28","author":"Vesikari","year":"2009","journal-title":"Vaccine"},{"issue":"11","key":"poi210012r14","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1016\/j.vaccine.2011.01.004","article-title":"Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 oral suspension (liquid formulation) in Finnish infants.","volume":"29","author":"Vesikari","year":"2011","journal-title":"Vaccine"},{"issue":"22","key":"poi210012r15","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1016\/j.vaccine.2006.03.025","article-title":"Effects of the potency and composition of the multivalent human-bovine (WC3) reassortant rotavirus vaccine on efficacy, safety and immunogenicity in healthy infants.","volume":"24","author":"Vesikari","year":"2006","journal-title":"Vaccine"},{"issue":"37","key":"poi210012r16","doi-asserted-by":"publisher","first-page":"6335","DOI":"10.1016\/j.vaccine.2011.05.017","article-title":"Efficacy, safety and immunogenicity of RIX4414 in Japanese infants during the first two years of life.","volume":"29","author":"Kawamura","year":"2011","journal-title":"Vaccine"},{"issue":"8","key":"poi210012r17","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.4161\/hv.24846","article-title":"Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial.","volume":"9","author":"Iwata","year":"2013","journal-title":"Hum Vaccin Immunother"},{"issue":"2","key":"poi210012r18","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1097\/INF.0b013e31815aba79","article-title":"Immunogenicity and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine in healthy infants in Korea.","volume":"27","author":"Kim","year":"2008","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"poi210012r19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.4161\/hv.19853","article-title":"Immunogenicity, reactogenicity and safety of a human rotavirus vaccine (RIX4414) in Korean infants: a randomized, double-blind, placebo-controlled, phase IV study.","volume":"8","author":"Kim","year":"2012","journal-title":"Hum Vaccin Immunother"},{"issue":"43","key":"poi210012r20","doi-asserted-by":"publisher","first-page":"5936","DOI":"10.1016\/j.vaccine.2009.07.098","article-title":"Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study.","volume":"27","author":"Phua","year":"2009","journal-title":"Vaccine"},{"issue":"30","key":"poi210012r21","doi-asserted-by":"publisher","first-page":"4552","DOI":"10.1016\/j.vaccine.2012.03.030","article-title":"Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: a randomized clinical trial in an Asian population.","volume":"30","author":"Phua","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"poi210012r22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.47102\/annals-acadmedsg.V45N2p44","article-title":"Efficacy, immunogenicity and safety of a human rotavirus vaccine RIX4414 in Singaporean infants.","volume":"45","author":"Phua","year":"2016","journal-title":"Ann Acad Med Singap"},{"key":"poi210012r23","doi-asserted-by":"publisher","first-page":"S6","DOI":"10.1086\/jid.2005.192.issue-s1","article-title":"Evaluation of RIX4414, a live, attenuated rotavirus vaccine, in a randomized, double-blind, placebo-controlled phase 2 trial involving 2464 Singaporean infants.","volume":"192","author":"Phua","year":"2005","journal-title":"J Infect Dis"},{"issue":"1","key":"poi210012r24","doi-asserted-by":"publisher","first-page":"11","DOI":"10.4161\/hv.26319","article-title":"Human rotavirus vaccine (RIX4414) efficacy in the first two years of life: a randomized, placebo-controlled trial in China.","volume":"10","author":"Li","year":"2014","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"poi210012r25","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1080\/21645515.2015.1085143","article-title":"Immunogenicity and reactogenicity of the human rotavirus vaccine, RIX4414 oral suspension, when co-administered with routine childhood vaccines in Chinese infants.","volume":"12","author":"Li","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"18","key":"poi210012r26","doi-asserted-by":"publisher","first-page":"2253","DOI":"10.1016\/j.vaccine.2013.03.001","article-title":"Efficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: a randomized, controlled trial.","volume":"31","author":"Lau","year":"2013","journal-title":"Vaccine"},{"issue":"43","key":"poi210012r27","doi-asserted-by":"publisher","first-page":"5897","DOI":"10.1016\/j.vaccine.2017.08.081","article-title":"Efficacy and safety of a pentavalent live human-bovine reassortant rotavirus vaccine (RV5) in healthy Chinese infants: a randomized, double-blind, placebo-controlled trial.","volume":"35","author":"Mo","year":"2017","journal-title":"Vaccine"},{"issue":"13","key":"poi210012r28","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1016\/j.vaccine.2019.02.018","article-title":"Immunogenicity of pentavalent rotavirus vaccine in Chinese infants.","volume":"37","author":"Mo","year":"2019","journal-title":"Vaccine"},{"issue":"4","key":"poi210012r29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/S0929-6646(09)60067-X","article-title":"Experience of pentavalent human-bovine reassortant rotavirus vaccine among healthy infants in Taiwan.","volume":"108","author":"Chang","year":"2009","journal-title":"J Formos Med Assoc"},{"issue":"46","key":"poi210012r30","doi-asserted-by":"publisher","first-page":"7393","DOI":"10.1016\/j.vaccine.2020.04.038","article-title":"Efficacy, immunogenicity and safety of a trivalent live human-lamb reassortant rotavirus vaccine (LLR3) in healthy Chinese infants: a randomized, double-blind, placebo-controlled trial.","volume":"38","author":"Xia","year":"2020","journal-title":"Vaccine"},{"issue":"5","key":"poi210012r31","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1093\/cid\/ciw346","article-title":"Delayed dosing of oral rotavirus vaccine demonstrates decreased risk of rotavirus gastroenteritis associated with serum zinc: a randomized controlled trial.","volume":"63","author":"Colgate","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"9","key":"poi210012r32","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1016\/j.vaccine.2008.12.059","article-title":"Successful co-administration of a human rotavirus and oral poliovirus vaccines in Bangladeshi infants in a 2-dose schedule at 12 and 16 weeks of age.","volume":"27","author":"Zaman","year":"2009","journal-title":"Vaccine"},{"issue":"9741","key":"poi210012r33","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1016\/S0140-6736(10)60755-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial.","volume":"376","author":"Zaman","year":"2010","journal-title":"Lancet"},{"issue":"11","key":"poi210012r34","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1016\/j.vaccine.2011.01.018","article-title":"Immunogenicity, reactogenicity and safety of the human rotavirus vaccine RIX4414 (Rotarix\u2122) oral suspension (liquid formulation) when co-administered with expanded program on immunization (EPI) vaccines in Vietnam and the Philippines in 2006-2007.","volume":"29","author":"Anh","year":"2011","journal-title":"Vaccine"},{"issue":"6","key":"poi210012r35","doi-asserted-by":"publisher","first-page":"414","DOI":"10.4161\/hv.5.6.8176","article-title":"Immunogenicity, reactogenicity and safety of human rotavirus vaccine (RIX4414) in Indian infants.","volume":"5","author":"Narang","year":"2009","journal-title":"Hum Vaccin"},{"issue":"3","key":"poi210012r36","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1086\/599175","article-title":"A dose-escalation safety and immunogenicity study of live attenuated oral rotavirus vaccine 116E in infants: a randomized, double-blind, placebo-controlled trial.","volume":"200","author":"Bhandari","year":"2009","journal-title":"J Infect Dis"},{"key":"poi210012r37","doi-asserted-by":"publisher","first-page":"A104","DOI":"10.1016\/j.vaccine.2014.03.036","article-title":"Active surveillance for intussusception in a phase III efficacy trial of an oral monovalent rotavirus vaccine in India.","volume":"32","author":"John","year":"2014","journal-title":"Vaccine"},{"issue":"9935","key":"poi210012r38","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1016\/S0140-6736(13)62630-6","article-title":"Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial.","volume":"383","author":"Bhandari","year":"2014","journal-title":"Lancet"},{"issue":"45","key":"poi210012r39","doi-asserted-by":"publisher","first-page":"6228","DOI":"10.1016\/j.vaccine.2017.09.014","article-title":"A randomized phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants.","volume":"35","author":"Kulkarni","year":"2017","journal-title":"Vaccine"},{"issue":"6","key":"poi210012r40","doi-asserted-by":"publisher","first-page":"e103","DOI":"10.1097\/INF.0b013e3182138278","article-title":"Human rotavirus vaccine is highly efficacious when coadministered with routine expanded program of immunization vaccines including oral poliovirus vaccine in Latin America.","volume":"30","author":"Tregnaghi","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"9619","key":"poi210012r41","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/S0140-6736(08)60524-3","article-title":"Efficacy and safety of an oral live attenuated human rotavirus vaccine against rotavirus gastroenteritis during the first 2 years of life in Latin American infants: a randomised, double-blind, placebo-controlled phase III study.","volume":"371","author":"Linhares","year":"2008","journal-title":"Lancet"},{"issue":"9","key":"poi210012r42","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1097\/01.inf.0000178294.13954.a1","article-title":"Evaluation of safety, immunogenicity and efficacy of an attenuated rotavirus vaccine, RIX4414: a randomized, placebo-controlled trial in Latin American infants.","volume":"24","author":"Salinas","year":"2005","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"poi210012r43","doi-asserted-by":"publisher","first-page":"e253","DOI":"10.1542\/peds.2006-2630","article-title":"Dose response and efficacy of a live, attenuated human rotavirus vaccine in Mexican infants.","volume":"120","author":"Ruiz-Palacios","year":"2007","journal-title":"Pediatrics"},{"issue":"7","key":"poi210012r44","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1590\/S0074-02762012000700002","article-title":"Oral live attenuated human rotavirus vaccine (Rotarix\u2122) offers sustained high protection against severe G9P[8] rotavirus gastroenteritis during the first two years of life in Brazilian children.","volume":"107","author":"Justino","year":"2012","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"6","key":"poi210012r45","doi-asserted-by":"publisher","first-page":"e1499","DOI":"10.1542\/peds.2010-1240","article-title":"Pentavalent rotavirus vaccine in developing countries: safety and health care resource utilization.","volume":"126","author":"Christie","year":"2010","journal-title":"Pediatrics"},{"issue":"12","key":"poi210012r46","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1056\/NEJMoa1609462","article-title":"Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger.","volume":"376","author":"Isanaka","year":"2017","journal-title":"N Engl J Med"},{"issue":"25","key":"poi210012r47","doi-asserted-by":"publisher","first-page":"3674","DOI":"10.1016\/j.vaccine.2018.05.023","article-title":"Safety of a heat-stable rotavirus vaccine among children in Niger: data from a phase 3, randomized, double-blind, placebo-controlled trial.","volume":"36","author":"Coldiron","year":"2018","journal-title":"Vaccine"},{"issue":"4","key":"poi210012r48","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1056\/NEJMoa0904797","article-title":"Effect of human rotavirus vaccine on severe diarrhea in African infants.","volume":"362","author":"Madhi","year":"2010","journal-title":"N Engl J Med"},{"key":"poi210012r49","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1186\/1471-2334-12-213","article-title":"Human rotavirus vaccine Rotarix\u2122 provides protection against diverse circulating rotavirus strains in African infants: a randomized controlled trial.","volume":"12","author":"Steele","year":"2012","journal-title":"BMC Infect Dis"},{"key":"poi210012r50","doi-asserted-by":"publisher","first-page":"S93","DOI":"10.1086\/654890","article-title":"Comparison of 2 different regimens for reactogenicity, safety, and immunogenicity of the live attenuated oral rotavirus vaccine RIX4414 coadministered with oral polio vaccine in South African infants.","volume":"202","author":"Steele","year":"2010","journal-title":"J Infect Dis"},{"key":"poi210012r51","doi-asserted-by":"publisher","first-page":"A36","DOI":"10.1016\/j.vaccine.2011.09.120","article-title":"Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: a randomized, double-blind, placebo controlled trial.","volume":"30","author":"Cunliffe","year":"2012","journal-title":"Vaccine"},{"issue":"2","key":"poi210012r52","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1089\/vim.2006.0105","article-title":"Evaluation of circulating intestinally committed memory B cells in children vaccinated with attenuated human rotavirus vaccine.","volume":"20","author":"Rojas","year":"2007","journal-title":"Viral Immunol"},{"issue":"9741","key":"poi210012r53","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0140-6736(10)60889-6","article-title":"Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial.","volume":"376","author":"Armah","year":"2010","journal-title":"Lancet"},{"key":"poi210012r54","doi-asserted-by":"publisher","first-page":"A79","DOI":"10.1016\/j.vaccine.2012.01.022","article-title":"Secondary efficacy endpoints of the pentavalent rotavirus vaccine against gastroenteritis in sub-Saharan Africa.","volume":"30","author":"Tapia","year":"2012","journal-title":"Vaccine"},{"key":"poi210012r55","doi-asserted-by":"publisher","first-page":"A71","DOI":"10.1016\/j.vaccine.2011.11.094","article-title":"Efficacy of the oral pentavalent rotavirus vaccine in Mali.","volume":"30","author":"Sow","year":"2012","journal-title":"Vaccine"},{"key":"poi210012r56","doi-asserted-by":"publisher","first-page":"A61","DOI":"10.1016\/j.vaccine.2011.09.026","article-title":"Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(\u00ae), in Kenya, including among HIV-infected and HIV-exposed infants.","volume":"30","author":"Laserson","year":"2012","journal-title":"Vaccine"},{"issue":"5","key":"poi210012r57","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1016\/0923-2516(91)90008-Q","article-title":"Evaluation of the efficacy of a low-passage bovine rotavirus (strain WC3) vaccine in children in Central Africa.","volume":"142","author":"Georges-Courbot","year":"1991","journal-title":"Res Virol"},{"issue":"1","key":"poi210012r58","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1056\/NEJMoa052434","article-title":"Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis.","volume":"354","author":"Ruiz-Palacios","year":"2006","journal-title":"N Engl J Med"},{"key":"poi210012r59","doi-asserted-by":"publisher","first-page":"A24","DOI":"10.1016\/j.vaccine.2011.08.124","article-title":"Analyses of health outcomes from the 5 sites participating in the Africa and Asia clinical efficacy trials of the oral pentavalent rotavirus vaccine.","volume":"30","author":"Breiman","year":"2012","journal-title":"Vaccine"},{"issue":"1","key":"poi210012r60","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1542\/peds.2006-2058","article-title":"Efficacy, immunogenicity, and safety of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine at the end of shelf life.","volume":"119","author":"Block","year":"2007","journal-title":"Pediatrics"},{"issue":"1","key":"poi210012r61","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"poi210012r62","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1097\/INF.0b013e318168d29e","article-title":"Efficacy of pentavalent human-bovine (WC3) reassortant rotavirus vaccine based on breastfeeding frequency.","volume":"27","author":"Goveia","year":"2008","journal-title":"Pediatr Infect Dis J"},{"key":"poi210012r63","doi-asserted-by":"publisher","first-page":"S36","DOI":"10.1016\/S1201-9712(07)60020-4","article-title":"The integrated phase III safety profile of the pentavalent human-bovine (WC3) reassortant rotavirus vaccine.","volume":"11","author":"Dennehy","year":"2007","journal-title":"Int J Infect Dis"},{"key":"poi210012r64","doi-asserted-by":"publisher","first-page":"S29","DOI":"10.1016\/S1201-9712(07)60019-8","article-title":"Efficacy of a pentavalent rotavirus vaccine in reducing rotavirus-associated health care utilization across three regions (11 countries).","volume":"11","author":"Vesikari","year":"2007","journal-title":"Int J Infect Dis"},{"issue":"1","key":"poi210012r65","doi-asserted-by":"publisher","first-page":"e25","DOI":"10.1542\/peds.2012-3804","article-title":"Effectiveness of monovalent and pentavalent rotavirus vaccine.","volume":"132","author":"Cortese","year":"2013","journal-title":"Pediatrics"},{"key":"poi210012r66","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.jpeds.2016.01.042","article-title":"Sustained effectiveness of monovalent and pentavalent rotavirus vaccines in children.","volume":"172","author":"Immergluck","year":"2016","journal-title":"J Pediatr"},{"issue":"2","key":"poi210012r67","doi-asserted-by":"publisher","first-page":"e267","DOI":"10.1542\/peds.2010-3722","article-title":"Effectiveness of pentavalent rotavirus vaccine against severe disease.","volume":"128","author":"Staat","year":"2011","journal-title":"Pediatrics"},{"issue":"8","key":"poi210012r68","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.3201\/eid1908.130461","article-title":"Comparison of 2 assays for diagnosing rotavirus and evaluating vaccine effectiveness in children with gastroenteritis.","volume":"19","author":"Tate","year":"2013","journal-title":"Emerg Infect Dis"},{"issue":"24","key":"poi210012r69","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.1016\/j.vaccine.2013.03.072","article-title":"Determining the effectiveness of the pentavalent rotavirus vaccine against rotavirus hospitalizations and emergency department visits using two study designs.","volume":"31","author":"Donauer","year":"2013","journal-title":"Vaccine"},{"issue":"2","key":"poi210012r70","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1542\/peds.2009-1021","article-title":"Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.","volume":"125","author":"Boom","year":"2010","journal-title":"Pediatrics"},{"issue":"6","key":"poi210012r71","doi-asserted-by":"publisher","first-page":"e1474","DOI":"10.1542\/peds.2011-1006","article-title":"Leveraging state immunization information systems to measure the effectiveness of rotavirus vaccine.","volume":"128","author":"Cortese","year":"2011","journal-title":"Pediatrics"},{"issue":"51","key":"poi210012r72","doi-asserted-by":"publisher","first-page":"7307","DOI":"10.1016\/j.vaccine.2015.10.118","article-title":"Effectiveness of monovalent rotavirus vaccine in a high-income, predominant-use setting.","volume":"33","author":"Doll","year":"2015","journal-title":"Vaccine"},{"key":"poi210012r73","doi-asserted-by":"publisher","first-page":"c2825","DOI":"10.1136\/bmj.c2825","article-title":"Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study.","volume":"340","author":"de Palma","year":"2010","journal-title":"BMJ"},{"key":"poi210012r74","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e4752","article-title":"Effectiveness of rotavirus vaccination in prevention of hospital admissions for rotavirus gastroenteritis among young children in Belgium: case-control study.","volume":"345","author":"Braeckman","year":"2012","journal-title":"BMJ"},{"issue":"10","key":"poi210012r75","doi-asserted-by":"publisher","first-page":"O702","DOI":"10.1111\/1469-0691.12612","article-title":"Higher proportion of G2P[4] rotaviruses in vaccinated hospitalized cases compared with unvaccinated hospitalized cases, despite high vaccine effectiveness against heterotypic G2P[4] rotaviruses.","volume":"20","author":"Matthijnssens","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"3","key":"poi210012r76","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/j.vaccine.2011.11.071","article-title":"Effectiveness of rotavirus vaccines in preventing cases and hospitalizations due to rotavirus gastroenteritis in Navarre, Spain.","volume":"30","author":"Castilla","year":"2012","journal-title":"Vaccine"},{"key":"poi210012r77","doi-asserted-by":"crossref","DOI":"10.1016\/j.jvacx.2019.100005","article-title":"Effectiveness of oral rotavirus vaccination in England against rotavirus-confirmed and all-cause acute gastroenteritis.","volume":"1","author":"Walker","year":"2019","journal-title":"Vaccine X"},{"issue":"10","key":"poi210012r78","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1080\/21645515.2020.1726679","article-title":"Retrospective multicenter matched case-control study on the risk factors for intussusception in infants less than 1 year of age with a special focus on rotavirus vaccines\u2014the German Intussusception Study.","volume":"16","author":"Oberle","year":"2020","journal-title":"Hum Vaccin Immunother"},{"key":"poi210012r79","doi-asserted-by":"publisher","first-page":"S140","DOI":"10.1093\/cid\/civ1209","article-title":"Impact of rotavirus vaccine introduction and vaccine effectiveness in the Republic of Moldova.","volume":"62","author":"Gheorghita","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"poi210012r80","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1086\/599187","article-title":"Rotavirus and the indigenous children of the Australian outback: monovalent vaccine effective in a high-burden setting.","volume":"49","author":"Snelling","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"10","key":"poi210012r81","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/cid\/cit520","article-title":"Intussusception risk and disease prevention associated with rotavirus vaccines in Australia\u2019s National Immunization Program.","volume":"57","author":"Carlin","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"4","key":"poi210012r82","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-1024","article-title":"Rotavirus epidemiology and monovalent rotavirus vaccine effectiveness in Australia: 2010-2017.","volume":"144","author":"Maguire","year":"2019","journal-title":"Pediatrics"},{"issue":"34","key":"poi210012r83","doi-asserted-by":"publisher","first-page":"5187","DOI":"10.1016\/j.vaccine.2018.07.007","article-title":"Effectiveness of monovalent and pentavalent rotavirus vaccines in Japanese children.","volume":"36","author":"Araki","year":"2018","journal-title":"Vaccine"},{"issue":"8","key":"poi210012r84","doi-asserted-by":"publisher","first-page":"282","DOI":"10.2188\/jea.JE20180054","article-title":"Case-control study of rotavirus vaccine effectiveness compared to test-negative controls or hospital controls.","volume":"29","author":"Araki","year":"2019","journal-title":"J Epidemiol"},{"issue":"1","key":"poi210012r85","doi-asserted-by":"publisher","first-page":"14291","DOI":"10.1038\/s41598-018-32595-9","article-title":"Effectiveness of monovalent rotavirus vaccine in the Philippines.","volume":"8","author":"Lopez","year":"2018","journal-title":"Sci Rep"},{"issue":"1","key":"poi210012r86","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.cmi.2017.04.018","article-title":"Effectiveness of rotavirus pentavalent vaccine under a universal immunization programme in Israel, 2011-2015: a case-control study.","volume":"24","author":"Muhsen","year":"2018","journal-title":"Clin Microbiol Infect"},{"issue":"2","key":"poi210012r87","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1080\/21645515.2020.1776034","article-title":"Rotavirus vaccine effectiveness and impact in Uzbekistan, the first country to introduce in central Asia.","volume":"17","author":"Eraliev","year":"2021","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"poi210012r88","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1097\/INF.0000000000000105","article-title":"Effectiveness of 2 rotavirus vaccines against rotavirus disease in Taiwanese infants.","volume":"33","author":"Chang","year":"2014","journal-title":"Pediatr Infect Dis J"},{"issue":"52","key":"poi210012r89","doi-asserted-by":"publisher","first-page":"8756","DOI":"10.1016\/j.vaccine.2007.10.036","article-title":"Effectiveness of Lanzhou lamb rotavirus vaccine against rotavirus gastroenteritis requiring hospitalization: a matched case-control study.","volume":"25","author":"Fu","year":"2007","journal-title":"Vaccine"},{"issue":"1","key":"poi210012r90","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1016\/j.vaccine.2012.10.078","article-title":"Effectiveness of the Lanzhou lamb rotavirus vaccine against gastroenteritis among children.","volume":"31","author":"Fu","year":"2012","journal-title":"Vaccine"},{"issue":"10","key":"poi210012r91","article-title":"Effectiveness of the live attenuated rotavirus vaccine produced by a domestic manufacturer in China studied using a population-based case-control design.","volume":"4","author":"Zhen","year":"2015","journal-title":"Emerg Microbes Infect"},{"issue":"27","key":"poi210012r92","doi-asserted-by":"publisher","first-page":"3611","DOI":"10.1016\/j.vaccine.2019.03.069","article-title":"Effectiveness of Lanzhou lamb rotavirus vaccine in preventing gastroenteritis among children younger than 5 years of age.","volume":"37","author":"Li","year":"2019","journal-title":"Vaccine"},{"issue":"21","key":"poi210012r93","doi-asserted-by":"publisher","first-page":"2243","DOI":"10.1001\/jama.2009.756","article-title":"Association between pentavalent rotavirus vaccine and severe rotavirus diarrhea among children in Nicaragua.","volume":"301","author":"Patel","year":"2009","journal-title":"JAMA"},{"issue":"11","key":"poi210012r94","doi-asserted-by":"publisher","first-page":"e209","DOI":"10.1097\/INF.0b013e31822a8527","article-title":"Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua.","volume":"30","author":"Mast","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"2","key":"poi210012r95","doi-asserted-by":"publisher","first-page":"e365","DOI":"10.1542\/peds.2011-3478","article-title":"Duration of protection of pentavalent rotavirus vaccination in Nicaragua.","volume":"130","author":"Patel","year":"2012","journal-title":"Pediatrics"},{"key":"poi210012r96","doi-asserted-by":"publisher","first-page":"S121","DOI":"10.1093\/cid\/civ1208","article-title":"Effectiveness of monovalent and pentavalent rotavirus vaccines in Guatemala.","volume":"62","author":"Gasta\u00f1aduy","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"poi210012r97","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1086\/649521","article-title":"Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P[4] strains in Brazil.","volume":"201","author":"Correia","year":"2010","journal-title":"J Infect Dis"},{"key":"poi210012r98","doi-asserted-by":"publisher","first-page":"f3726","DOI":"10.1136\/bmj.f3726","article-title":"Effectiveness of monovalent rotavirus vaccine in Bolivia: case-control study.","volume":"346","author":"Patel","year":"2013","journal-title":"BMJ"},{"issue":"23","key":"poi210012r99","doi-asserted-by":"publisher","first-page":"2740","DOI":"10.1016\/j.vaccine.2014.01.007","article-title":"Effectiveness of rotavirus vaccine against hospitalized rotavirus diarrhea: a case-control study.","volume":"32","author":"Ichihara","year":"2014","journal-title":"Vaccine"},{"issue":"5","key":"poi210012r100","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/INF.0b013e3182055cc2","article-title":"Effectiveness of the monovalent G1P[8] human rotavirus vaccine against hospitalization for severe G2P[4] rotavirus gastroenteritis in Bel\u00e9m, Brazil.","volume":"30","author":"Justino","year":"2011","journal-title":"Pediatr Infect Dis J"},{"issue":"24","key":"poi210012r101","doi-asserted-by":"publisher","first-page":"2283","DOI":"10.1056\/NEJMoa1012952","article-title":"Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil.","volume":"364","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"key":"poi210012r102","doi-asserted-by":"publisher","first-page":"S115","DOI":"10.1093\/cid\/civ1026","article-title":"Sustained effectiveness of rotavirus vaccine against very severe rotavirus disease through the second year of life, Bolivia 2013-2014.","volume":"62","author":"Pringle","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"25","key":"poi210012r103","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1016\/j.vaccine.2014.03.064","article-title":"Effectiveness of the monovalent rotavirus vaccine in Colombia: a case-control study.","volume":"32","author":"Cotes-Cantillo","year":"2014","journal-title":"Vaccine"},{"key":"poi210012r104","doi-asserted-by":"publisher","first-page":"S175","DOI":"10.1093\/cid\/civ1206","article-title":"A preliminary assessment of rotavirus vaccine effectiveness in Zambia.","volume":"62","author":"Beres","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"4","key":"poi210012r105","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1473-3099(14)71060-6","article-title":"Effectiveness of a monovalent rotavirus vaccine in infants in Malawi after programmatic roll-out: an observational and case-control study.","volume":"15","author":"Bar-Zeev","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"poi210012r106","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1016\/S1473-3099(14)70940-5","article-title":"Effectiveness of monovalent human rotavirus vaccine against admission to hospital for acute rotavirus diarrhoea in South African children: a case-control study.","volume":"14","author":"Groome","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"8","key":"poi210012r107","doi-asserted-by":"publisher","first-page":"1606","DOI":"10.1093\/cid\/ciz431","article-title":"Evaluation of intussusception after oral monovalent rotavirus vaccination in South Africa.","volume":"70","author":"Groome","year":"2020","journal-title":"Clin Infect Dis"},{"key":"poi210012r108","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.1093\/cid\/civ1207","article-title":"Effectiveness of monovalent rotavirus vaccine after programmatic implementation in Botswana: a multisite prospective case-control study.","volume":"62","author":"Gasta\u00f1aduy","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"3","key":"poi210012r109","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1097\/INF.0000000000001828","article-title":"Evaluation of the influence of gastrointestinal coinfections on rotavirus vaccine effectiveness in Botswana.","volume":"37","author":"Mokomane","year":"2018","journal-title":"Pediatr Infect Dis J"},{"key":"poi210012r110","doi-asserted-by":"publisher","first-page":"S200","DOI":"10.1093\/cid\/ciw014","article-title":"Impact and effectiveness of monovalent rotavirus vaccine against severe rotavirus diarrhea in Ghana.","volume":"62","author":"Armah","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"47","key":"poi210012r111","doi-asserted-by":"publisher","first-page":"7170","DOI":"10.1016\/j.vaccine.2017.12.056","article-title":"Impact and effectiveness of pentavalent rotavirus vaccine in children <5 years of age in Burkina Faso.","volume":"36","author":"Bonkoungou","year":"2018","journal-title":"Vaccine"},{"key":"poi210012r112","doi-asserted-by":"publisher","first-page":"S208","DOI":"10.1093\/cid\/civ1016","article-title":"Effectiveness of pentavalent rotavirus vaccine under conditions of routine use in Rwanda.","volume":"62","author":"Tate","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"8","key":"poi210012r113","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1093\/cid\/ciy1096","article-title":"Monovalent rotavirus vaccine effectiveness against rotavirus hospitalizations among children in Zimbabwe.","volume":"69","author":"Mujuru","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"11","key":"poi210012r114","doi-asserted-by":"publisher","first-page":"2298","DOI":"10.1093\/cid\/ciz664","article-title":"Effectiveness of monovalent rotavirus vaccine against hospitalization with acute rotavirus gastroenteritis in Kenyan children.","volume":"70","author":"Khagayi","year":"2020","journal-title":"Clin Infect Dis"},{"issue":"2","key":"poi210012r115","doi-asserted-by":"publisher","first-page":"e208","DOI":"10.1542\/peds.2009-1246","article-title":"Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.","volume":"125","author":"Wang","year":"2010","journal-title":"Pediatrics"},{"issue":"3","key":"poi210012r116","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1097\/INF.0b013e318275328f","article-title":"Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.","volume":"32","author":"Wang","year":"2013","journal-title":"Pediatr Infect Dis J"},{"issue":"6","key":"poi210012r117","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1001\/jama.2012.97","article-title":"Risk of intussusception following administration of a pentavalent rotavirus vaccine in US infants.","volume":"307","author":"Shui","year":"2012","journal-title":"JAMA"},{"issue":"37","key":"poi210012r118","doi-asserted-by":"publisher","first-page":"5065","DOI":"10.1016\/j.vaccine.2017.06.034","article-title":"Public health impact of Rotarix vaccination among commercially insured children in the United States.","volume":"35","author":"Krishnarajah","year":"2017","journal-title":"Vaccine"},{"issue":"7","key":"poi210012r119","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1080\/21645515.2018.1450123","article-title":"Safety study of live, oral human rotavirus vaccine: a cohort study in United States health insurance plans.","volume":"14","author":"Hoffman","year":"2018","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"poi210012r120","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1080\/21645515.2016.1189038","article-title":"Effectiveness of rotavirus vaccine in preventing severe gastroenteritis in young children according to socioeconomic status.","volume":"12","author":"Gosselin","year":"2016","journal-title":"Hum Vaccin Immunother"},{"issue":"3","key":"poi210012r121","doi-asserted-by":"crossref","first-page":"614","DOI":"10.5114\/aoms.2016.59935","article-title":"The effectiveness of rotavirus vaccine in preventing acute gastroenteritis during rotavirus seasons among Polish children.","volume":"12","author":"Mrozek-Budzyn","year":"2016","journal-title":"Arch Med Sci"},{"key":"poi210012r122","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1186\/s12879-015-0811-5","article-title":"Effectiveness of rotavirus vaccines, licensed but not funded, against rotavirus hospitalizations in the Valencia region, Spain.","volume":"15","author":"P\u00e9rez-Vilar","year":"2015","journal-title":"BMC Infect Dis"},{"issue":"21","key":"poi210012r123","doi-asserted-by":"publisher","first-page":"3753","DOI":"10.1016\/j.vaccine.2011.03.035","article-title":"Impact of rotavirus vaccination on hospitalizations for rotavirus diarrhea: the IVANHOE study.","volume":"29","author":"Gagneur","year":"2011","journal-title":"Vaccine"},{"issue":"1","key":"poi210012r124","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.vaccine.2010.10.010","article-title":"The uptake of rotavirus vaccine and its effectiveness in preventing acute gastroenteritis in the community.","volume":"29","author":"Muhsen","year":"2010","journal-title":"Vaccine"},{"issue":"4","key":"poi210012r125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002282","article-title":"Effectiveness of a live oral human rotavirus vaccine after programmatic introduction in Bangladesh: a cluster-randomized trial.","volume":"14","author":"Zaman","year":"2017","journal-title":"PLoS Med"},{"issue":"5","key":"poi210012r126","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.vaccine.2016.12.043","article-title":"Evaluating the first introduction of rotavirus vaccine in Thailand: moving from evidence to policy.","volume":"35","author":"Tharmaphornpilas","year":"2017","journal-title":"Vaccine"},{"issue":"3","key":"poi210012r127","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1590\/S0074-02762011000300012","article-title":"Acute diarrhoea in a community cohort of children who received an oral rotavirus vaccine in Northeast Brazil.","volume":"106","author":"Vieira","year":"2011","journal-title":"Mem Inst Oswaldo Cruz"},{"issue":"9","key":"poi210012r128","doi-asserted-by":"publisher","first-page":"e1036","DOI":"10.1016\/S2214-109X(18)30314-0","article-title":"Impact of monovalent rotavirus vaccine on diarrhoea-associated post-neonatal infant mortality in rural communities in Malawi: a population-based birth cohort study.","volume":"6","author":"Bar-Zeev","year":"2018","journal-title":"Lancet Glob Health"},{"issue":"9","key":"poi210012r129","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/S1473-3099(14)70832-1","article-title":"Distribution of rotavirus strains and strain-specific effectiveness of the rotavirus vaccine after its introduction: a systematic review and meta-analysis.","volume":"14","author":"Leshem","year":"2014","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"poi210012r130","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1128\/jcm.26.4.732-738.1988","article-title":"Comparison of serum and mucosal antibody responses following severe acute rotavirus gastroenteritis in young children.","volume":"26","author":"Grimwood","year":"1988","journal-title":"J Clin Microbiol"},{"issue":"6","key":"poi210012r131","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1086\/jid.2000.182.issue-6","article-title":"Serum antibody as a marker of protection against natural rotavirus infection and disease.","volume":"182","author":"Vel\u00e1zquez","year":"2000","journal-title":"J Infect Dis"},{"issue":"10","key":"poi210012r132","article-title":"Vaccines for preventing rotavirus diarrhoea: vaccines in use.","volume":"2019","author":"Soares-Weiser","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"poi210012r133","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1186\/s12879-017-2613-4","article-title":"Population effectiveness of the pentavalent and monovalent rotavirus vaccines: a systematic review and meta-analysis of observational studies.","volume":"17","author":"Hungerford","year":"2017","journal-title":"BMC Infect Dis"},{"issue":"9","key":"poi210012r134","doi-asserted-by":"publisher","first-page":"992","DOI":"10.1097\/INF.0000000000001232","article-title":"A systematic review of the effect of rotavirus vaccination on diarrhea outcomes among children younger than 5 Years.","volume":"35","author":"Lamberti","year":"2016","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"poi210012r135","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1093\/infdis\/jiaa081","article-title":"Global impact of rotavirus vaccination on diarrhea hospitalizations and deaths among children <5 years old: 2006-2019.","volume":"222","author":"Burnett","year":"2020","journal-title":"J Infect Dis"},{"issue":"10","key":"poi210012r136","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.12458","article-title":"Association between rotavirus vaccination and risk of intussusception among neonates and infants: a systematic review and meta-analysis.","volume":"2","author":"Lu","year":"2019","journal-title":"JAMA Netw Open"},{"issue":"7","key":"poi210012r137","first-page":"53","article-title":"Global advisory committee on vaccine safety, 11\u201312 December 2013.","volume":"89","author":"WHO","year":"2014","journal-title":"wkly epidemiol rec"},{"issue":"10","key":"poi210012r138","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1093\/cid\/cit520","article-title":"Intussusception risk and disease prevention associated with rotavirus vaccines in Australia\u2019s National Immunization Program.","volume":"57","author":"Carlin","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"6","key":"poi210012r139","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1093\/cid\/ciz060","article-title":"Global review of the age distribution of rotavirus disease in children aged <5 years before the introduction of rotavirus vaccination.","volume":"69","author":"Hasso-Agopsowicz","year":"2019","journal-title":"Clin Infect Dis"},{"issue":"7","key":"poi210012r140","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1016\/S1473-3099(19)30126-4","article-title":"Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials.","volume":"19","author":"Clark","year":"2019","journal-title":"Lancet Infect Dis"},{"issue":"5","key":"poi210012r141","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1093\/cid\/cix369","article-title":"Effectiveness of rotavirus vaccination: a systematic review of the first decade of global postlicensure data, 2006-2016.","volume":"65","author":"Jonesteller","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"5","key":"poi210012r142","doi-asserted-by":"publisher","first-page":"563","DOI":"10.4161\/hv.7.5.15406","article-title":"Efficacy of the pentavalent rotavirus vaccine, RotaTeq\u00ae (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen).","volume":"7","author":"Dennehy","year":"2011","journal-title":"Hum Vaccin"},{"key":"poi210012r143","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1086\/654890","article-title":"Rotavirus strain types circulating in Africa: review of studies published during 1997-2006.","volume":"202","author":"Todd","year":"2010","journal-title":"J Infect Dis"},{"issue":"1","key":"poi210012r144","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1002\/(ISSN)1099-1654","article-title":"Global distribution of rotavirus serotypes\/genotypes and its implication for the development and implementation of an effective rotavirus vaccine.","volume":"15","author":"Santos","year":"2005","journal-title":"Rev Med Virol"},{"issue":"3","key":"poi210012r145","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00705-007-0028-z","article-title":"Apparent extinction of non-G2 rotavirus strains from circulation in Recife, Brazil, after the introduction of rotavirus vaccine.","volume":"153","author":"Nakagomi","year":"2008","journal-title":"Arch Virol"},{"issue":"1","key":"poi210012r146","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3201\/eid1501.071136","article-title":"Rotavirus genotype distribution after vaccine introduction, Rio de Janeiro, Brazil.","volume":"15","author":"Carvalho-Costa","year":"2009","journal-title":"Emerg Infect Dis"},{"issue":"6","key":"poi210012r147","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2019.24.6.1700774","article-title":"Impact of rotavirus vaccination on rotavirus genotype distribution and diversity in England, September 2006 to August 2016.","volume":"24","author":"Hungerford","year":"2019","journal-title":"Euro Surveill"},{"issue":"10","key":"poi210012r148","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.2217\/fmb.09.96","article-title":"Rotavirus disease and vaccination: impact on genotype diversity.","volume":"4","author":"Matthijnssens","year":"2009","journal-title":"Future Microbiol"},{"issue":"1","key":"poi210012r149","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1056\/NEJMoa052664","article-title":"Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine.","volume":"354","author":"Vesikari","year":"2006","journal-title":"N Engl J Med"},{"issue":"4","key":"poi210012r150","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1086\/522499","article-title":"Efficacy of the human rotavirus vaccine RIX4414 in malnourished children.","volume":"196","author":"Perez-Schael","year":"2007","journal-title":"J Infect Dis"},{"issue":"11","key":"poi210012r151","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.1016\/j.ebiom.2015.09.036","article-title":"Environmental enteropathy, oral vaccine failure and growth faltering in infants in Bangladesh.","volume":"2","author":"Naylor","year":"2015","journal-title":"EBioMedicine"},{"issue":"27","key":"poi210012r152","doi-asserted-by":"publisher","first-page":"3068","DOI":"10.1016\/j.vaccine.2016.04.080","article-title":"Impact of enterovirus and other enteric pathogens on oral polio and rotavirus vaccine performance in Bangladeshi infants.","volume":"34","author":"Taniuchi","year":"2016","journal-title":"Vaccine"},{"issue":"30","key":"poi210012r153","doi-asserted-by":"publisher","first-page":"4061","DOI":"10.1016\/j.vaccine.2019.05.086","article-title":"The distinct impact of maternal antibodies on the immunogenicity of live and recombinant rotavirus vaccines.","volume":"37","author":"Yang","year":"2019","journal-title":"Vaccine"},{"issue":"3","key":"poi210012r154","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-016577","article-title":"Impact of maternal antibodies and infant gut microbiota on the immunogenicity of rotavirus vaccines in African, Indian and European infants: protocol for a prospective cohort study.","volume":"7","author":"Sindhu","year":"2017","journal-title":"BMJ Open"},{"issue":"8","key":"poi210012r156","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0041720","article-title":"Understanding reduced rotavirus vaccine efficacy in low socio-economic settings.","volume":"7","author":"Lopman","year":"2012","journal-title":"PLoS One"},{"issue":"4","key":"poi210012r157","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1056\/NEJMoa1006261","article-title":"Protective effect of natural rotavirus infection in an Indian birth cohort.","volume":"365","author":"Gladstone","year":"2011","journal-title":"N Engl J Med"},{"key":"poi210012r158","doi-asserted-by":"publisher","first-page":"S220","DOI":"10.1093\/cid\/civ1025","article-title":"Cost-effectiveness of monovalent rotavirus vaccination of infants in Malawi: a postintroduction analysis using individual patient-level costing data.","volume":"62","author":"Bar-Zeev","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"1","key":"poi210012r159","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s12916-018-1134-3","article-title":"Updated cost-effectiveness and risk-benefit analysis of two infant rotavirus vaccination strategies in a high-income, low-endemic setting.","volume":"16","author":"Bruijning-Verhagen","year":"2018","journal-title":"BMC Med"},{"issue":"10","key":"poi210012r160","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0047511","article-title":"A cost effectiveness and capacity analysis for the introduction of universal rotavirus vaccination in Kenya: comparison between Rotarix and RotaTeq vaccines.","volume":"7","author":"van Hoek","year":"2012","journal-title":"PLoS One"},{"issue":"2","key":"poi210012r161","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0228506","article-title":"Introduction of rotavirus vaccination in Palestine: An evaluation of the costs, impact, and cost-effectiveness of Rotarix and Rotavac.","volume":"15","author":"Debellut","year":"2020","journal-title":"PLoS One"},{"issue":"18","key":"poi210012r162","doi-asserted-by":"publisher","first-page":"2097","DOI":"10.1016\/j.vaccine.2015.03.016","article-title":"Effectiveness and impact of rotavirus vaccines in Europe, 2006-2014.","volume":"33","author":"Karafillakis","year":"2015","journal-title":"Vaccine"},{"issue":"3","key":"poi210012r163","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1586\/14760584.2014.877846","article-title":"Effectiveness and impact of rotavirus vaccines in the United States: 2006-2012.","volume":"13","author":"Rha","year":"2014","journal-title":"Expert Rev Vaccines"},{"key":"poi210012r6","unstructured":"World Health Organization. Immunization, vaccines and biologicals. Updated October 2020. Accessed February 26, 2019. https:\/\/www.who.int\/immunization\/diseases\/rotavirus\/en\/"},{"key":"poi210012r155","unstructured":"Soares-Weiser? K. Rotavirus vaccine schedules: a systematic review of safety and efficacy from randomized controlled trials and observational studies of childhood schedules using RV1 and RV5 vaccines, report to WHO\/Initiative for Vaccine Research 2012. Published 2012. Accessed March 5, 2021. https:\/\/www.who.int\/immunization\/sage\/meetings\/2012\/april\/Soares_K_et_al_SAGE_April_rotavirus.pdf"}],"container-title":["JAMA Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/articlepdf\/2779857\/jamapediatrics_sun_2021_oi_210012_1625081128.96633.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,26]],"date-time":"2022-12-26T17:41:44Z","timestamp":1672076504000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamapediatrics\/fullarticle\/2779857"}},"subtitle":["A Systematic Review and Meta-analysis of Randomized Clinical Trials and Observational Studies"],"short-title":[],"issued":{"date-parts":[[2021,7,6]]},"references-count":163,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamapediatrics.2021.0347","relation":{},"ISSN":["2168-6203"],"issn-type":[{"value":"2168-6203","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7,6]]}}}